MBX Biosciences Ownership | Who Owns MBX Biosciences?
MBX Biosciences Ownership Summary
MBX Biosciences is owned by 58.05% institutional investors, 2.84% insiders, and 39.11% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 19.89% of MBX shares.
MBX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | MBX Biosciences | 58.05% | 2.84% | 39.11% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 6.65M | 19.89% | $116.41M |
| Wellington management group llp | 4.82M | 14.42% | $84.41M |
| Orbimed advisors | 4.00M | 11.97% | $70.05M |
| Nea management company | 3.61M | 10.81% | $63.25M |
| Deep track capital, lp | 3.15M | 9.42% | $55.13M |
| Blackrock funding, inc. /de | 2.92M | 8.54% | $92.09M |
| Nvp associates | 2.14M | 6.39% | $37.39M |
| Ecor1 capital | 2.12M | 6.35% | $37.16M |
| Kynam capital management, lp | 2.00M | 5.98% | $35.00M |
| Vanguard group | 1.82M | 5.32% | $57.33M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Nvp associates | 2.14M | 22.51% | $37.39M |
| Frazier life sciences management | 6.65M | 3.49% | $116.41M |
| Nea management company | 3.61M | 3.47% | $63.25M |
| Kynam capital management, lp | 2.00M | 2.61% | $35.00M |
| Ecor1 capital | 2.12M | 1.78% | $37.16M |
| Orbimed advisors | 4.00M | 1.65% | $70.05M |
| Deep track capital, lp | 3.15M | 1.54% | $55.13M |
| Cormorant asset management, lp | 1.23M | 1.48% | $21.44M |
| Parkman healthcare partners | 773.30K | 1.41% | $13.53M |
| Opaleye management | 253.00K | 0.63% | $4.43M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 4.82M | 0.01% | 2.56M |
| Kynam capital management, lp | 2.00M | 2.61% | 2.00M |
| Ecor1 capital | 2.12M | 1.78% | 973.81K |
| Blackrock funding, inc. /de | 2.92M | 0.00% | 962.29K |
| Deep track capital, lp | 3.15M | 1.54% | 961.41K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Franklin resources | - | - | -1.31M |
| Bioimpact capital | - | - | -1.29M |
| Price t rowe associates inc /md/ | 954.73K | 0.00% | -392.18K |
| Ra capital management | - | - | -377.84K |
| Schonfeld strategic advisors | 282.68K | 0.03% | -348.74K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Kynam capital management, lp | 2.00M | 2.61% | 2.00M | $35.00M |
| Rock springs capital management lp | 282.62K | 0.29% | 282.62K | $4.95M |
| Baker bros. advisors lp | 277.78K | 0.04% | 277.78K | $4.86M |
| Longaeva partners | 224.43K | 0.57% | 224.43K | $3.93M |
| Goelzer investment management | 221.67K | 0.32% | 221.67K | $6.99M |
Sold Out
| Holder | Change |
|---|---|
| Rise advisors | -68.00 |
| Comerica bank | -76.00 |
| Washington trust advisors | -83.00 |
| Srs capital advisors | -398.00 |
| Raymond james financial | -761.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 81 | -39.10% | 19,853,942 | -58.46% | 58 | 0.30% | 63 | -14.86% | 9 | -70.00% |
| Sep 30, 2025 | 130 | 42.86% | 47,138,465 | 27.96% | 140 | 1.16% | 73 | 21.67% | 30 | 100.00% |
| Jun 30, 2025 | 91 | 15.19% | 36,839,365 | 3.29% | 110 | 0.97% | 60 | -24.05% | 15 | - |
| Mar 31, 2025 | 1 | - | 1,579,207 | - | 4 | - | 1 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 20, 2025 | Hawryluk P. Kent | President & CEO | Buy | $272.79K |
| Oct 17, 2025 | Hoerter Steven L. | - | Buy | $264.98K |
| Sep 26, 2025 | Heron Patrick J | Buy | $12.00M | |
| Apr 08, 2025 | Pescovitz Ora H. | - | Buy | $45.31K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | 2 | - |
| 2025 Q3 | 1 | - |
| 2025 Q2 | 1 | - |
MBX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools